Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Closing New Hampshire Plant, Consolidating with North Carolina Operations

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific will be transferring laboratory equipment manufacturing operations from a facility in New Hampshire to North Carolina, the company said.

As a result, 109 positions at the Newington, NH, facility will be eliminated, though 110 jobs will be added to the Asheville, NC, plant, a Thermo Fisher spokesman confirmed. The jobs are being added to help build a new line of temperature controls for scientific equipment.

Separately, 13 laboratory equipment assembly jobs at Thermo Fisher's Portsmouth, NH, site are being transferred to the company's plant in Marietta, Ohio.

The Newington facility is expected to close down by the end of the first quarter 2012, the company said.

"Our leadership team continuously evaluates our geographic footprint in an effort to increase efficiencies and improve our competitive position globally," Thermo Fisher said in a statement. "As part of this evaluation, the dynamics of current market conditions, including costs for energy, labor and raw materials, are assessed.

"We will do everything possible to support the 109 employees at [the Newington] site who are affected and follow all mandated processes," the company added. "Business decisions that result in the loss of jobs are always difficult. However, these actions are designed to strengthen our operations, help us better serve our customers worldwide and provide continued growth opportunities for our 37,000 employees in the long term."

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.